Mesirow Financial Investment Management - Fixed Income’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-398,885
| Closed | -$11.5M | – | 95 |
|
|
2022
Q2 | $11.5M | Buy |
398,885
+19,010
| +5% | +$550K | 1.48% | 14 |
|
|
2022
Q1 | $12.3M | Sell |
379,875
-100
| -0% | -$3.23K | 1.36% | 22 |
|
|
2021
Q4 | $11.1M | Buy |
379,975
+48,835
| +15% | +$1.42M | 1.22% | 22 |
|
|
2021
Q3 | $8.83M | Buy |
+331,140
| New | +$8.83M | 1.02% | 43 |
|
|
2019
Q2 | – | Sell |
-163,691
| Closed | -$5.74M | – | 132 |
|
|
2019
Q1 | $5.74M | Buy |
163,691
+46,805
| +40% | +$1.64M | 0.89% | 65 |
|
|
2018
Q4 | $3.88M | Sell |
116,886
-127,470
| -52% | -$4.23M | 0.52% | 74 |
|
|
2018
Q3 | $12.3M | Sell |
244,356
-12,045
| -5% | -$606K | 1.12% | 49 |
|
|
2018
Q2 | $15.3M | Sell |
256,401
-25,655
| -9% | -$1.54M | 1.41% | 18 |
|
|
2018
Q1 | $12.9M | Sell |
282,056
-95,405
| -25% | -$4.37M | 1.27% | 40 |
|
|
2017
Q4 | $15M | Buy |
377,461
+22,506
| +6% | +$897K | 1.06% | 66 |
|
|
2017
Q3 | $14.2M | Buy |
354,955
+142,215
| +67% | +$5.69M | 0.94% | 74 |
|
|
2017
Q2 | $9.17M | Buy |
+212,740
| New | +$9.17M | 0.61% | 74 |
|